Evidence map›Paper›PMID 41966642›Full record

ReviewAbdominal radiology (New York)2026

MR-based techniques for imaging prostate cancer metabolism: current status and future perspectives.

Xueqing Cheng, Jinshun Xu, Jin Yao, Bin Song

Abstract readReview
PubMed Publisher
In one paragraph

Review in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xueqing ChengDepartment of Radiology, West China Hospital of Sichuan University, Chengdu, China.
Jinshun XuDepartment of Ultrasound, Sichuan Cancer Hospital, Chengdu, China.
Jin YaoDepartment of Radiology, West China Hospital of Sichuan University, Chengdu, China. shelleyyao@163.com.
Bin SongDepartment of Radiology, West China Hospital of Sichuan University, Chengdu, China. songlab_radiology@163.com.

Funding

1.3.5 project for disciplines of excellence，West China Hospital, Sichuan University ZYGD22004China Postdoctoral Science Foundation 2023M732436National Natural Science Foundation of China 82502427Natural Science Foundation of Sichuan Province 2024NSFSC1790
6 · The paper itself

Abstract

Prostate cancer (PCa) is a heterogeneous disease ranging from indolent to highly aggressive forms (e.g., castration-resistant PCa). Although multiparametric MRI plays an important role in the routine diagnosis and management of PCa, emerging challenges underscore a critical unmet need in the era of precision and personalized medicine. Given that metabolic reprogramming is a hallmark of PCa, metabolic imaging techniques that focus on and target changes in metabolic pathways, such as PET and hyperpolarized (HP)

Indexed as

Hyperpolarized 13C MRIMagnetic resonance spectroscopyMetabolic imagingMetabolic reprogrammingProstate cancer

Identifiers

PMID41966642

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.